首页> 美国卫生研究院文献>Medicines >Anti-Diabetic Potential of Ocimum gratissimum Leaf Fractions in Fortified Diet-Fed Streptozotocin Treated Rat Model of Type-2 Diabetes
【2h】

Anti-Diabetic Potential of Ocimum gratissimum Leaf Fractions in Fortified Diet-Fed Streptozotocin Treated Rat Model of Type-2 Diabetes

机译:强化饮食喂养的链脲佐菌素治疗的2型糖尿病大鼠模型中免费提供的柠檬叶部分的抗糖尿病潜力

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

>Background: Ocimum gratissimum (OG) is used in the traditional management of diabetes in Nigeria. This study investigated the anti-diabetic potential of OG leaf fractions (OGLF) in a rat model of Type-2 diabetes (T2D). >Methods: Methanol crude extract of OG leaf was fractionated with solvents of increasing order of polarity (n-hexane, chloroform, ethyl-acetate, n-butanol and water). The anti-diabetic potential of the fractions was evaluated in vivo. T2D was induced in Albino Wistar rats and treated with OGLF. >Results: The T2D rats showed significant elevation in serum levels of fasting blood glucose (FBG), liver and kidney function biomarkers. At 4-week of intervention with OGLF, the untreated diabetic control group maintained severe hyperglycaemia in the presence of 61.7% serum insulin, 17.3% pancreatic β-cell function (HOMA-β) and 51.5% Insulin sensitivity. The glucose tolerance ability was enhanced in the n-butanol-fraction (OGb) treated group. With 74.8% available serum insulin and 38.6% improvement in insulin sensitivity, the OGb treated group had a 63.5% reduction in FBG and it was found to be most effective as it ameliorates a majority of the changes caused in the studied parameters in diabetic rats. >Conclusions: The data from this study suggest that OGb fraction is a potential candidate for the development of an effective drug for the management of T2D.
机译:>背景:尼日利亚免费使用Ocimum gratissimum(OG)。这项研究调查了2型糖尿病(T2D)大鼠模型中OG叶片级分(OGLF)的抗糖尿病潜力。 >方法:将OG叶的甲醇粗提物用极性递增的溶剂(正己烷,氯仿,乙酸乙酯,正丁醇和水)分级分离。在体内评估了级分的抗糖尿病潜力。 T2D在白化Wistar大鼠中诱导并用OGLF处理。 >结果:T2D大鼠的空腹血糖(FBG),肝肾功能生物标志物的血清水平明显升高。在接受OGLF干预的4周中,未经治疗的糖尿病对照组在存在61.7%血清胰岛素,17.3%胰腺β细胞功能(HOMA-β)和51.5%胰岛素敏感性的情况下维持严重的高血糖症。在正丁醇级分(OGb)处理组中,葡萄糖耐受能力增强。 OGb治疗组具有74.8%的可用血清胰岛素和38.6%的胰岛素敏感性改善,其FBG降低了63.5%,并且被发现是最有效的,因为它可以缓解糖尿病大鼠研究参数引起的大部分变化。 >结论:这项研究的数据表明OGb组分是开发有效的T2D治疗药物的潜在候选者。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号